肝虚血の英語

虚血・再灌流傷害から組織を保護し得る虚血・再灌流傷害抑制剤、例えば肝臓虚血再灌流傷害（ショック、敗血症、肝切除、肝外傷、肝移植等）の予防剤及び／又は治療剤を提供すること。例文帳に追加

To provide an ischemia and reperfusion damage inhibitor that can protect the tissues from an ischemia and reperfusion damage, for example, a prophylactic and/or therapeutic agent for hepatic ischemia and reperfusion damage (for example, shock, septicemia, hepatic resection, hepatic trauma and liver transplantation and the like). - 特許庁

心筋梗塞、脳梗塞、肝炎又は心臓・肺・肝臓・小腸・膵臓・腎臓の虚血再灌流障害等の、アポトーシスを伴う疾患の予防又は治療剤を提供すること。例文帳に追加

To provide a prophylactic or therapeutic agent for diseases accompanied by apoptosis, such as cardiac infarction, cerebral infarction, hepatitis, or ischemic reperfusion injury in heart, lung, liver, small intestine, pancreas and kidney. - 特許庁

抗アポトーシス物質であるBcl-xLの５２番目及び６６番目のアスパラギンの両者をアラニンに置換した修飾Bcl-xLを投与又は細胞内で発言させることにより、心筋梗塞、脳梗塞、肝炎又は心臓・肺・肝臓・小腸・膵臓・腎臓の虚血再灌流障害等の、アポトーシスを伴う疾患の予防又は治療を行う。例文帳に追加

In Bcl-xL that is an anti-apoptotic substance, both of asparagines at positions 52 and 66 are each substituted with alanine and the modified Bcl-xL is administered or expressed in the cells to carry out the prophylaxis and therapy for the diseases accompanied by apoptosis, such as cardiac infarction, cerebral infarction, hepatitis, or ischemic reperfusion injury in heart, lung, liver, small intestine, pancreas and kidney. - 特許庁

該シクロスポリン誘導体は型肝炎ウイルス感染、およびヒト免疫不全ウイルス感染の治療又は予防に有効であり、またシクロスポリンの長期間投与で、生ずる不可逆的な腎機能障害、縞状線維化から房の虚血性虚脱、糸球体硬化、及び尿細管萎縮等の毒性に対して良好な毒性プロファイルを有する。例文帳に追加

The cyclosporin derivative is effective for the treatment or prevention of the hepatitis C infection and human immunodeficiency virus infection, and has a good toxicological profile against, in prolonged cyclosporine administration, irreversible impairment of renal function, from striped fibrosis to ischemic collapse of the tuft, glomerular sclerosis and tubular atrophy, etc. - 特許庁

肥満予防・改善、体脂肪燃焼促進、脂肪酸代謝活性化、インスリン抵抗性予防・改善、糖尿病予防・改善、脂質異常症予防・改善、脂肪肝予防・改善、動脈硬化予防・改善、持久力向上、心肥大予防・改善、虚血性心疾患予防・改善に有効なペルオキシソーム増殖剤活性化受容体（ＰＰＡＲ）活性化剤の提供。例文帳に追加

To provide a peroxisomal proliferator-activated receptor (PPAR)-activating agent which is effective for preventing and improving obesity, promoting the combustion of body fats, activating the metabolism of fatty acids, preventing and improving insulin resistance, preventing and improving diabetes, preventing and improving dyslipidemia, preventing and improving fatty liver, preventing and improving arteriosclerosis, improving endurance, preventing and improving cardiomegaly, and preventing and improving ischemic heart diseases. - 特許庁

ＨＯＥＦＣ１１ポリペプチドおよびポリヌクレオチド、ならびに組み換え法によるかかるポリペプチドの製造方法、ならびに、とりわけ慢性腎不全、炎症性疾患、心筋虚血、癌、リューマチ性関節炎、硬変性肝臓疾患の治療プロトコールの設計、ならびにかかる症状の診断における該ポリペプチドおよびポリヌクレオチドの使用を提供する。例文帳に追加

To provide a HOEFC11 polypeptide, to provide a polynucleotide encoding the polypeptide, to provide a method for producing the polypeptide by recombination method, to provide a design of a therapeutic protocol especially for chronic renal insufficiency, inflammatory diseases, myocardial ischemia, cancer, rheumatic arthritics and cirrhotic hepatopathy, and to provide uses of both the polypeptide and polynucleotide in diagnosing such symptoms as mentioned above. - 特許庁